Microplastics could accelerate antibiotic resistance, studies find
Plastic pollution and drug-resistant infections are usually regarded as separate global crises. But emerging research suggests links between them: Microplastic particles in the environment are colonised by bacteria, and those bacteria develop antibiotic resistance at an unprecedented rate.
Abatify Summary
**The colonization of microplastics by drug-resistant bacteria introduces a toxic vector that degrades ecological health and undermines the biological integrity of critical carbon sinks.**
- Microplastics act as artificial substrates (the 'plastisphere') that accelerate horizontal gene transfer of antibiotic-resistant genes among microbial communities, threatening biodiversity baseline health.
- Contaminated marine and terrestrial microenvironments alter the microbial balance, potentially degrading the carbon sequestration capacity of LULUCF and coastal Blue Carbon ecosystems.
- The bioaccumulation of plastic-associated pathogens up the trophic web compromises the long-term ecological stability and adaptive capacity of fragile marine habitats.
**This emerging intersection of plastic pollution and pathogen transmission raises systemic sovereign risks, threatening the integrity of ICVCM CCP-aligned environmental assets.**
- Regulators may tighten environmental safety standards, adjusting the 'Do No Harm' safeguards under ICVCM Core Carbon Principles (CCPs) to penalize projects failing to mitigate plastic-induced biohazards.
- Market pricing for nature-based solutions may discount carbon credits from regions with high microplastic pollution due to increased permanence risks and biological instability.
- Corporate compliance frameworks, including SBTi and Scope 3 supply chain disclosures, are likely to expand to mandate integrated plastic-reduction and ecological toxicity metrics.
